Ephraim Resources (ASX:EPA) Debt-to-EBITDA : -1.03 (As of Dec. 2017)

What is Ephraim Resources Debt-to-EBITDA?

Ephraim Resources ASX:EPA Debt-to-EBITDA is -1.03 as of Dec. 2017. The stock has 1 warning sign investors should review.

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ephraim Resources's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2017 was A$0.53 Mil. Ephraim Resources's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2017 was A$0.00 Mil. Ephraim Resources's annualized EBITDA for the quarter that ended in Dec. 2017 was A$-0.51 Mil. Ephraim Resources's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2017 was -1.03.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Ephraim Resources's Debt-to-EBITDA or its related term are showing as below:

ASX:EPA's Debt-to-EBITDA is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.14
* Ranked among companies with meaningful Debt-to-EBITDA only.

Ephraim Resources (ASX:EPA) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Ephraim Resources Debt-to-EBITDA Related Terms

Ephraim Resources Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Ephraim Resources's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ephraim Resources Debt-to-EBITDA Chart

Ephraim Resources Annual Data

Trend

Jun09

Jun10

Jun11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Debt-to-EBITDA

Get a 7-Day Free Trial

-0.39

0.00

-0.15

-1.24

-0.64

Ephraim Resources Semi-Annual Data
	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18
Debt-to-EBITDA	Get a 7-Day Free Trial															-0.14	-0.87	-1.77	-1.03	-0.46

Ephraim Resources Debt-to-EBITDA Competitor Comparison

For the Biotechnology subindustry, Ephraim Resources's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ephraim Resources Debt-to-EBITDA vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ephraim Resources's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ephraim Resources's Debt-to-EBITDA falls into.

Save Embed

Ephraim Resources Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ephraim Resources's Debt-to-EBITDA for the fiscal year that ended in Jun. 2018 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.55	+	0)	/	-0.858
	=	-0.64

Ephraim Resources's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2017 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.526	+	0)	/	-0.51
	=	-1.03

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2017) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →

What does a Debt-to-EBITDA of -1.03 mean?

Ephraim Resources (ASX:EPA) has a Debt-to-EBITDA of -1.03 as of Dec. 2017. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Ephraim Resources.

Is Ephraim Resources' Debt-to-EBITDA too high?

Ephraim Resources' current Debt-to-EBITDA is -1.03.

How does Ephraim Resources' Debt-to-EBITDA compare to competitors?

Ephraim Resources' Debt-to-EBITDA of -1.03 can be compared against companies in the Biotechnology industry. The industry median Debt-to-EBITDA is 1.14. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Debt-to-EBITDA for a Biotechnology company?

The median Debt-to-EBITDA among Biotechnology companies is 1.14, based on 291 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Debt-to-EBITDA mean?

A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Ephraim Resources. For the Biotechnology industry, the median Debt-to-EBITDA is 1.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ephraim Resources's current Debt-to-EBITDA is -1.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Ephraim Resources stock overvalued right now?

Ephraim Resources (ASX:EPA) has a current Debt-to-EBITDA of -1.03. The current Debt-to-EBITDA is -1.03. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Debt-to-EBITDA calculated?

Debt-to-EBITDA is calculated from a company's financial statements. For Ephraim Resources (ASX:EPA), the current Debt-to-EBITDA is -1.03 as of Dec. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ephraim Resources Business Description

Industry Healthcare Biotechnology

Comparable Companies ASX:ACL ASX:PAB ASX:BIT ASX:BXN ASX:PIQ ASX:PTX ASX:GBI ASX:RHS ASX:IIL ASX:RAC ASX:RNO ASX:HCT ASX:DXB ASX:BTC ASX:SUD ASX:BOT ASX:POH ASX:RGS ASX:IVQ ASX:CDY

Address C/- Nexia Perth, 88 William Street, Level 3, Perth, WA, AUS, 6000

Website http://www.ephraimresources.com.au

Ephraim Resources Ltd is an Australia-based company involved in agricultural biogenetics research and experimentation, licensing and consultancy, with a focus on nipah palm breeding, tissue culture, cultivation and plantation, and producing sugar syrup from nipah palm sap.